Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-19

Clinical Trial Update: Study of the Efficacy and Tolerance of Oral Treatment With a Total Freeze-dried Culture of Lcr Restituo® Sachets (Lactobacillus Rhamnosus Lcr35®) on Intolerance to Metformin (Diarrhoea) in Patients With Diabetes Type 2 [Phase 2]

View source ↗

Summary

Phase 2 trial assessing oral Lcr Restituo (Lactobacillus rhamnosus Lcr35) for metformin-induced diarrhea in type 2 diabetes patients; status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lcr Restituo (Lactobacillus rhamnosus Lcr35)

Snippet

Sponsor: Biose | Conditions: Antidiarrhoea | Phase 2 | Status: UNKNOWN